Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,400 | 84,701 | 100,905 | 310 | 591 |
| Other current assets | 0 | 0 | 0 | 10 | 5 |
| TOTAL | $73,799 | $87,831 | $102,407 | $423 | $757 |
| Non-Current Assets | |||||
| PPE Net | 3,499 | 3,686 | 3,278 | N/A | N/A |
| Investments And Advances | 0 | 0 | 0 | 100,126 | 100,204 |
| Other Non-Current Assets | 3,250 | 2,137 | 1,528 | 0 | 0 |
| TOTAL | $6,749 | $5,823 | $4,806 | $100,126 | $100,204 |
| Total Assets | $80,548 | $93,654 | $107,213 | $100,549 | $100,960 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,466 | 3,919 | 2,247 | 329 | 181 |
| Accrued Expenses | 3,982 | 3,596 | 6,422 | N/A | N/A |
| TOTAL | $5,969 | $8,020 | $9,159 | $329 | $181 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,474 | 16,116 | 19,452 | 95,220 | 95,780 |
| TOTAL | $6,474 | $16,116 | $19,452 | $95,220 | $95,780 |
| Total Liabilities | $12,443 | $24,136 | $28,611 | $95,549 | $95,960 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,658 | 3,658 | 3,785 | 1,250 | 1,250 |
| Common Shares | 4 | 4 | 4 | 0 | 0 |
| Retained earnings | -69,657 | -67,450 | -58,393 | -5,149 | -1,579 |
| TOTAL | $68,105 | $69,518 | $78,602 | $5,000 | $5,000 |
| Total Liabilities And Equity | $80,548 | $93,654 | $107,213 | $100,549 | $100,960 |